Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Teaching Rounds | 10 | 2024 | 282 | 4.130 |
Why?
|
Histamine H2 Antagonists | 1 | 2024 | 169 | 0.860 |
Why?
|
HIV Infections | 32 | 2024 | 17591 | 0.820 |
Why?
|
Primary Health Care | 13 | 2021 | 4748 | 0.790 |
Why?
|
Diverticulitis | 1 | 2023 | 187 | 0.710 |
Why?
|
Practice Guidelines as Topic | 10 | 2021 | 7460 | 0.700 |
Why?
|
Proton Pump Inhibitors | 1 | 2024 | 552 | 0.650 |
Why?
|
Acquired Immunodeficiency Syndrome | 7 | 2024 | 2203 | 0.640 |
Why?
|
Prostatic Hyperplasia | 1 | 2023 | 523 | 0.640 |
Why?
|
Gastroesophageal Reflux | 1 | 2024 | 836 | 0.560 |
Why?
|
Anti-HIV Agents | 7 | 2024 | 4576 | 0.540 |
Why?
|
Gallstones | 1 | 2019 | 285 | 0.530 |
Why?
|
Hypogonadism | 1 | 2021 | 805 | 0.480 |
Why?
|
CD4 Lymphocyte Count | 11 | 2019 | 2598 | 0.460 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2013 | 56 | 0.440 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 2013 | 664 | 0.430 |
Why?
|
Substance Abuse, Intravenous | 7 | 2013 | 530 | 0.430 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1106 | 0.420 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 2 | 2011 | 138 | 0.420 |
Why?
|
Pancreatitis | 1 | 2019 | 1087 | 0.390 |
Why?
|
Alcoholism | 8 | 2013 | 1981 | 0.390 |
Why?
|
Bone Diseases | 1 | 2015 | 416 | 0.380 |
Why?
|
Internal Medicine | 3 | 2021 | 1064 | 0.370 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1568 | 0.350 |
Why?
|
Testosterone | 1 | 2021 | 2493 | 0.350 |
Why?
|
Mass Screening | 4 | 2022 | 5457 | 0.350 |
Why?
|
Program Development | 1 | 2016 | 1300 | 0.350 |
Why?
|
Lipectomy | 1 | 2011 | 114 | 0.340 |
Why?
|
Physical Examination | 1 | 2016 | 1262 | 0.330 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2022 | 2044 | 0.330 |
Why?
|
Cytomegalovirus | 1 | 2013 | 753 | 0.320 |
Why?
|
Decision Making | 2 | 2021 | 3953 | 0.310 |
Why?
|
Disease Management | 1 | 2019 | 2537 | 0.310 |
Why?
|
Aortic Valve Stenosis | 1 | 2021 | 2034 | 0.310 |
Why?
|
Mental Health Services | 1 | 2020 | 1732 | 0.300 |
Why?
|
Sinusitis | 1 | 2017 | 998 | 0.290 |
Why?
|
Drug Prescriptions | 1 | 2017 | 1673 | 0.280 |
Why?
|
Genetic Testing | 1 | 2020 | 3591 | 0.280 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1388 | 0.280 |
Why?
|
Guideline Adherence | 2 | 2016 | 2241 | 0.260 |
Why?
|
Patient Compliance | 5 | 2011 | 2701 | 0.260 |
Why?
|
Hepatitis C | 6 | 2013 | 1595 | 0.250 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2422 | 0.250 |
Why?
|
Memory Disorders | 1 | 2012 | 1202 | 0.240 |
Why?
|
Internship and Residency | 4 | 2021 | 5956 | 0.240 |
Why?
|
Counseling | 1 | 2011 | 1554 | 0.210 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7478 | 0.210 |
Why?
|
Humans | 59 | 2024 | 768970 | 0.210 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2023 | 173 | 0.210 |
Why?
|
Attitude to Health | 2 | 2011 | 2025 | 0.200 |
Why?
|
Blood Pressure | 1 | 2018 | 8544 | 0.200 |
Why?
|
Anti-Retroviral Agents | 5 | 2024 | 1795 | 0.200 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2023 | 112 | 0.190 |
Why?
|
Alcohol Drinking | 6 | 2013 | 4045 | 0.180 |
Why?
|
Oxidoreductases | 1 | 2023 | 412 | 0.180 |
Why?
|
Vietnam | 3 | 2019 | 415 | 0.170 |
Why?
|
Aspartate Aminotransferases | 2 | 2019 | 414 | 0.170 |
Why?
|
Sex Reassignment Procedures | 1 | 2020 | 72 | 0.160 |
Why?
|
Outpatient Clinics, Hospital | 4 | 1995 | 395 | 0.160 |
Why?
|
Vaginal Smears | 1 | 2022 | 505 | 0.160 |
Why?
|
Male | 36 | 2023 | 365203 | 0.160 |
Why?
|
Alanine Transaminase | 2 | 2019 | 606 | 0.160 |
Why?
|
Hypertension | 1 | 2018 | 8617 | 0.150 |
Why?
|
Hepatitis C, Chronic | 1 | 2006 | 1033 | 0.150 |
Why?
|
Cognition Disorders | 1 | 2012 | 3985 | 0.150 |
Why?
|
Middle Aged | 20 | 2023 | 223737 | 0.150 |
Why?
|
Adult | 28 | 2022 | 223851 | 0.150 |
Why?
|
Israel | 1 | 2019 | 726 | 0.140 |
Why?
|
Acute Disease | 2 | 2019 | 7245 | 0.140 |
Why?
|
Referral and Consultation | 2 | 2020 | 3628 | 0.140 |
Why?
|
Gender Identity | 1 | 2023 | 770 | 0.140 |
Why?
|
Cholecystectomy | 1 | 2019 | 409 | 0.130 |
Why?
|
Genetic Counseling | 1 | 2020 | 634 | 0.130 |
Why?
|
HIV | 2 | 2019 | 1597 | 0.130 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2016 | 131 | 0.130 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2019 | 520 | 0.130 |
Why?
|
Peer Review, Health Care | 1 | 2016 | 73 | 0.130 |
Why?
|
Recurrence | 2 | 2019 | 8513 | 0.120 |
Why?
|
Female | 31 | 2024 | 397515 | 0.120 |
Why?
|
Colonoscopy | 1 | 2023 | 1410 | 0.120 |
Why?
|
Fluid Therapy | 1 | 2019 | 587 | 0.120 |
Why?
|
Androstadienes | 1 | 2016 | 348 | 0.120 |
Why?
|
Reminder Systems | 1 | 2018 | 388 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 1 | 2019 | 398 | 0.110 |
Why?
|
Risk Assessment | 6 | 2016 | 24333 | 0.110 |
Why?
|
Liver | 2 | 2019 | 7578 | 0.110 |
Why?
|
Self-Assessment | 1 | 2016 | 400 | 0.110 |
Why?
|
United States | 7 | 2024 | 73186 | 0.110 |
Why?
|
Public Sector | 1 | 2015 | 266 | 0.110 |
Why?
|
Depression | 5 | 2012 | 8231 | 0.110 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15661 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13698 | 0.110 |
Why?
|
Thromboembolism | 1 | 2020 | 1004 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 926 | 0.100 |
Why?
|
Estrogens | 1 | 2020 | 1536 | 0.100 |
Why?
|
Viral Load | 3 | 2019 | 3398 | 0.100 |
Why?
|
Drug Therapy, Combination | 1 | 2023 | 6320 | 0.100 |
Why?
|
Capacity Building | 1 | 2015 | 265 | 0.100 |
Why?
|
Enteral Nutrition | 1 | 2019 | 802 | 0.100 |
Why?
|
Aromatase Inhibitors | 1 | 2016 | 519 | 0.100 |
Why?
|
Risk Reduction Behavior | 2 | 2016 | 1119 | 0.100 |
Why?
|
Tamoxifen | 1 | 2016 | 967 | 0.100 |
Why?
|
Patient Preference | 1 | 2019 | 947 | 0.090 |
Why?
|
Chronic Disease | 3 | 2023 | 9384 | 0.090 |
Why?
|
Virus Diseases | 1 | 2017 | 724 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 1994 | 603 | 0.090 |
Why?
|
Alzheimer Disease | 1 | 2012 | 8760 | 0.090 |
Why?
|
Aftercare | 1 | 2016 | 921 | 0.080 |
Why?
|
Risk Factors | 7 | 2020 | 74976 | 0.080 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3709 | 0.080 |
Why?
|
Clinical Laboratory Techniques | 1 | 1994 | 749 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21188 | 0.080 |
Why?
|
Alcohol-Related Disorders | 2 | 2008 | 243 | 0.080 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2027 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1397 | 0.080 |
Why?
|
Echocardiography | 1 | 2021 | 5047 | 0.080 |
Why?
|
Weight Loss | 1 | 2019 | 2721 | 0.070 |
Why?
|
Immunoassay | 1 | 2011 | 746 | 0.070 |
Why?
|
Triage | 1 | 1994 | 997 | 0.070 |
Why?
|
Aged | 8 | 2024 | 171786 | 0.070 |
Why?
|
Postmenopause | 1 | 2016 | 2519 | 0.070 |
Why?
|
Biopsy | 1 | 2019 | 6805 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3238 | 0.070 |
Why?
|
Longevity | 1 | 2015 | 1077 | 0.070 |
Why?
|
Chi-Square Distribution | 3 | 2006 | 3438 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2023 | 65480 | 0.070 |
Why?
|
Vision Disorders | 1 | 2013 | 1093 | 0.070 |
Why?
|
Body Image | 1 | 2011 | 646 | 0.070 |
Why?
|
Prevalence | 3 | 2013 | 15879 | 0.070 |
Why?
|
Neoplasms | 1 | 2015 | 22389 | 0.060 |
Why?
|
Clinical Competence | 3 | 2016 | 4860 | 0.060 |
Why?
|
Prospective Studies | 11 | 2019 | 54962 | 0.060 |
Why?
|
Lymphatic Diseases | 1 | 1987 | 319 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2016 | 2784 | 0.060 |
Why?
|
Linear Models | 3 | 2013 | 5891 | 0.060 |
Why?
|
Informed Consent | 1 | 2011 | 1010 | 0.060 |
Why?
|
Guidelines as Topic | 1 | 2011 | 1399 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 13021 | 0.060 |
Why?
|
Cross-Sectional Studies | 6 | 2013 | 26395 | 0.060 |
Why?
|
Visual Acuity | 1 | 2013 | 2714 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2016 | 3443 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4607 | 0.050 |
Why?
|
Vitamin D | 1 | 2016 | 3311 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3782 | 0.050 |
Why?
|
Boston | 7 | 2016 | 9377 | 0.050 |
Why?
|
Liver Cirrhosis | 1 | 2013 | 1962 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3270 | 0.050 |
Why?
|
Quality Improvement | 2 | 2015 | 3860 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 3813 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5544 | 0.050 |
Why?
|
Zidovudine | 3 | 1992 | 625 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12095 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2182 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2016 | 4339 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2784 | 0.050 |
Why?
|
Time Factors | 5 | 2016 | 40261 | 0.050 |
Why?
|
Sexual Behavior | 1 | 2011 | 2200 | 0.050 |
Why?
|
Depressive Disorder | 3 | 2009 | 3723 | 0.050 |
Why?
|
Substance-Related Disorders | 2 | 2008 | 4423 | 0.050 |
Why?
|
Hospitals, Municipal | 3 | 1995 | 19 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 1994 | 3928 | 0.040 |
Why?
|
Health Behavior | 2 | 2007 | 2649 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2018 | 4879 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20776 | 0.040 |
Why?
|
HIV-1 | 3 | 2007 | 6962 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9621 | 0.040 |
Why?
|
Comorbidity | 3 | 2012 | 10592 | 0.040 |
Why?
|
Young Adult | 3 | 2022 | 60131 | 0.040 |
Why?
|
Blotting, Western | 1 | 2006 | 5033 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 2011 | 3269 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5375 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15471 | 0.030 |
Why?
|
HIV Protease Inhibitors | 1 | 1999 | 432 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2012 | 1903 | 0.030 |
Why?
|
Lithium | 1 | 1979 | 600 | 0.030 |
Why?
|
Cohort Studies | 8 | 2013 | 41808 | 0.030 |
Why?
|
Analysis of Variance | 2 | 1994 | 6236 | 0.030 |
Why?
|
Cocaine-Related Disorders | 2 | 2009 | 458 | 0.030 |
Why?
|
Staphylococcal Infections | 1 | 1984 | 1398 | 0.030 |
Why?
|
Medical Assistance | 1 | 2015 | 108 | 0.030 |
Why?
|
Risk-Taking | 2 | 2013 | 1023 | 0.030 |
Why?
|
Complementary Therapies | 1 | 1998 | 487 | 0.030 |
Why?
|
RNA, Viral | 3 | 2007 | 2871 | 0.030 |
Why?
|
Fees, Medical | 1 | 1994 | 111 | 0.030 |
Why?
|
Nuclear Family | 1 | 2015 | 311 | 0.030 |
Why?
|
Matched-Pair Analysis | 1 | 1994 | 286 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2018 | 443 | 0.030 |
Why?
|
Electrolytes | 1 | 1994 | 279 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 1990 | 8055 | 0.030 |
Why?
|
Massachusetts | 1 | 2006 | 8894 | 0.030 |
Why?
|
Liver Function Tests | 1 | 1994 | 526 | 0.030 |
Why?
|
Longitudinal Studies | 4 | 2013 | 14794 | 0.030 |
Why?
|
Information Systems | 1 | 1995 | 400 | 0.030 |
Why?
|
Sex Factors | 1 | 2006 | 10633 | 0.020 |
Why?
|
Inflammation | 1 | 2012 | 10868 | 0.020 |
Why?
|
AIDS-Related Complex | 2 | 1992 | 107 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 1994 | 390 | 0.020 |
Why?
|
Pharmacy Service, Hospital | 1 | 2012 | 134 | 0.020 |
Why?
|
Sexual Partners | 1 | 2015 | 807 | 0.020 |
Why?
|
Health Services Research | 1 | 2018 | 1818 | 0.020 |
Why?
|
Prognosis | 2 | 2006 | 30046 | 0.020 |
Why?
|
Sepsis | 1 | 1984 | 2610 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 59739 | 0.020 |
Why?
|
Age Factors | 1 | 2006 | 18435 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 1995 | 1196 | 0.020 |
Why?
|
Regression Analysis | 2 | 2009 | 6346 | 0.020 |
Why?
|
AIDS Serodiagnosis | 1 | 2009 | 220 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 1994 | 1321 | 0.020 |
Why?
|
Arthralgia | 1 | 2012 | 459 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2508 | 0.020 |
Why?
|
Syphilis Serodiagnosis | 1 | 1987 | 37 | 0.020 |
Why?
|
Heroin Dependence | 1 | 2008 | 173 | 0.020 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2007 | 155 | 0.020 |
Why?
|
Leukemia, Lymphoid | 1 | 1987 | 312 | 0.020 |
Why?
|
Software Design | 1 | 1987 | 173 | 0.020 |
Why?
|
Cell Death | 1 | 1992 | 1682 | 0.020 |
Why?
|
Infectious Mononucleosis | 1 | 1987 | 133 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 1992 | 1560 | 0.020 |
Why?
|
Health Expenditures | 1 | 1998 | 2396 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2012 | 716 | 0.020 |
Why?
|
Antiviral Agents | 2 | 2006 | 3070 | 0.020 |
Why?
|
Logistic Models | 2 | 2016 | 13318 | 0.020 |
Why?
|
Anthropometry | 1 | 2009 | 1345 | 0.010 |
Why?
|
Headache | 1 | 2012 | 1264 | 0.010 |
Why?
|
Connective Tissue Diseases | 1 | 1987 | 285 | 0.010 |
Why?
|
Sample Size | 1 | 2007 | 848 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 1990 | 941 | 0.010 |
Why?
|
Population Surveillance | 1 | 2013 | 2597 | 0.010 |
Why?
|
Awareness | 1 | 2007 | 653 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2434 | 0.010 |
Why?
|
Interferon Type I | 1 | 2006 | 569 | 0.010 |
Why?
|
Odds Ratio | 2 | 2009 | 9684 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 1979 | 5131 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1812 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2012 | 39394 | 0.010 |
Why?
|
Health Personnel | 1 | 2015 | 3383 | 0.010 |
Why?
|
Schizophrenia | 1 | 1979 | 6987 | 0.010 |
Why?
|
Disease Progression | 2 | 2007 | 13674 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2008 | 12562 | 0.010 |
Why?
|
Catheterization | 1 | 1984 | 1431 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2008 | 6030 | 0.010 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1999 | 242 | 0.010 |
Why?
|
Lymphoma | 1 | 1987 | 1900 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2001 | 752 | 0.010 |
Why?
|
Macrophages | 1 | 1992 | 5801 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6512 | 0.010 |
Why?
|
Medicare | 1 | 1994 | 6888 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 8094 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 1984 | 1430 | 0.010 |
Why?
|
Diagnostic Tests, Routine | 1 | 2001 | 790 | 0.010 |
Why?
|
Telephone | 1 | 1998 | 630 | 0.010 |
Why?
|
Survival Analysis | 1 | 2008 | 10115 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2018 | 81903 | 0.010 |
Why?
|
Cross Infection | 1 | 1984 | 1425 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1992 | 10276 | 0.010 |
Why?
|
Medical Records | 1 | 1998 | 1411 | 0.010 |
Why?
|
Homosexuality, Male | 1 | 2001 | 1344 | 0.010 |
Why?
|
Hospital Information Systems | 1 | 1995 | 394 | 0.010 |
Why?
|
Models, Statistical | 1 | 2007 | 5110 | 0.010 |
Why?
|
Models, Organizational | 1 | 1995 | 549 | 0.010 |
Why?
|
Community Health Centers | 1 | 1995 | 469 | 0.010 |
Why?
|
Syphilis, Latent | 1 | 1991 | 2 | 0.010 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 1991 | 82 | 0.010 |
Why?
|
AIDS Dementia Complex | 1 | 1991 | 155 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2001 | 2913 | 0.000 |
Why?
|
Health Services Needs and Demand | 1 | 1995 | 1407 | 0.000 |
Why?
|
Algorithms | 1 | 1987 | 14201 | 0.000 |
Why?
|
HIV Seropositivity | 1 | 1991 | 967 | 0.000 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1991 | 843 | 0.000 |
Why?
|
Occupational Diseases | 1 | 1991 | 1458 | 0.000 |
Why?
|
Hospitalization | 1 | 2001 | 10847 | 0.000 |
Why?
|
Occupational Exposure | 1 | 1991 | 1807 | 0.000 |
Why?
|